Treatment of these compounds inhibits MYC-dependent transactivation in colorectal cancer cells but not in stem cells or normal colon epithelial cells, and this effect is associated with the role of HUWE1 inhibition in stabilizing Miz1 and Miz1-mediated suppression of MYC target genes (29). The gene discussed is HUWE1; the disease is colorectal cancer.